REMSleep Holdings, Inc. (RMSL)
USD 0.01
(1.09%)
USD 0.01
(1.09%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 275.61 Thousand USD | -57.75% |
| 2022 | 652.36 Thousand USD | -25.87% |
| 2021 | 880 Thousand USD | -20.08% |
| 2020 | 1.1 Million USD | -12.82% |
| 2019 | 1.26 Million USD | 98.24% |
| 2018 | 637.16 Thousand USD | -6.48% |
| 2017 | 681.32 Thousand USD | 118.6% |
| 2016 | 311.68 Thousand USD | -0.62% |
| 2015 | 313.61 Thousand USD | -90.85% |
| 2014 | 3.42 Million USD | -1.09% |
| 2013 | 3.46 Million USD | 384.78% |
| 2012 | 714.9 Thousand USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 71.00 USD | -99.64% |
| 2009 | 19.78 Thousand USD | 349.66% |
| 2008 | 4400.00 USD | 39.68% |
| 2007 | 3150.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 481.42 Thousand USD | 74.67% |
| 2024 Q2 | 493.9 Thousand USD | 2.59% |
| 2023 Q1 | 507.87 Thousand USD | -22.15% |
| 2023 Q4 | 275.61 Thousand USD | -1.23% |
| 2023 Q2 | 294.15 Thousand USD | -42.08% |
| 2023 Q3 | 279.05 Thousand USD | -5.13% |
| 2023 FY | 275.61 Thousand USD | -57.75% |
| 2022 Q1 | 510.34 Thousand USD | -42.01% |
| 2022 Q4 | 652.36 Thousand USD | 1.35% |
| 2022 FY | 652.36 Thousand USD | -25.87% |
| 2022 Q3 | 643.65 Thousand USD | -6.81% |
| 2022 Q2 | 690.72 Thousand USD | 35.34% |
| 2021 Q2 | 1.11 Million USD | 11.26% |
| 2021 Q4 | 880 Thousand USD | -21.61% |
| 2021 Q3 | 1.12 Million USD | 0.49% |
| 2021 Q1 | 1 Million USD | -8.82% |
| 2021 FY | 880 Thousand USD | -20.08% |
| 2020 Q2 | 1.04 Million USD | -23.31% |
| 2020 Q4 | 1.1 Million USD | 17.38% |
| 2020 Q3 | 938.15 Thousand USD | -10.15% |
| 2020 FY | 1.1 Million USD | -12.82% |
| 2020 Q1 | 1.36 Million USD | 7.79% |
| 2019 Q1 | 1.23 Million USD | 93.66% |
| 2019 FY | 1.26 Million USD | 98.24% |
| 2019 Q2 | 1.34 Million USD | 8.98% |
| 2019 Q3 | 1.09 Million USD | -18.46% |
| 2019 Q4 | 1.26 Million USD | 15.2% |
| 2018 Q4 | 637.16 Thousand USD | 0.61% |
| 2018 Q3 | 633.3 Thousand USD | 31.05% |
| 2018 FY | 637.16 Thousand USD | -6.48% |
| 2018 Q2 | 483.25 Thousand USD | -1.21% |
| 2018 Q1 | 489.19 Thousand USD | -28.2% |
| 2017 Q1 | 331.11 Thousand USD | 6.24% |
| 2017 Q3 | 392.3 Thousand USD | 5.99% |
| 2017 Q2 | 370.14 Thousand USD | 11.79% |
| 2017 FY | 681.32 Thousand USD | 118.6% |
| 2017 Q4 | 681.32 Thousand USD | 73.68% |
| 2016 FY | 311.68 Thousand USD | -0.62% |
| 2016 Q2 | 339.6 Thousand USD | 0.89% |
| 2016 Q4 | 311.68 Thousand USD | -8.22% |
| 2016 Q3 | 339.6 Thousand USD | 0.0% |
| 2016 Q1 | 336.6 Thousand USD | 7.33% |
| 2015 Q3 | 400.18 Thousand USD | -0.25% |
| 2015 FY | 313.61 Thousand USD | -90.85% |
| 2015 Q4 | 313.61 Thousand USD | -21.63% |
| 2015 Q2 | 401.18 Thousand USD | 10.37% |
| 2015 Q1 | 363.48 Thousand USD | -89.4% |
| 2014 FY | 3.42 Million USD | -1.09% |
| 2014 Q1 | 3.83 Million USD | 10.72% |
| 2014 Q4 | 3.42 Million USD | 0.0% |
| 2014 Q3 | 3.42 Million USD | 0.52% |
| 2014 Q2 | 3.41 Million USD | -11.13% |
| 2013 Q2 | 1.12 Million USD | 21.59% |
| 2013 Q3 | 1.31 Million USD | 17.08% |
| 2013 Q4 | 3.46 Million USD | 164.21% |
| 2013 FY | 3.46 Million USD | 384.78% |
| 2013 Q1 | 921.41 Thousand USD | 28.89% |
| 2012 Q1 | 14.72 Thousand USD | 0.0% |
| 2012 Q4 | 714.9 Thousand USD | 588.88% |
| 2012 Q3 | 103.77 Thousand USD | 51.38% |
| 2012 FY | 714.9 Thousand USD | 0.0% |
| 2012 Q2 | 68.55 Thousand USD | 365.66% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q2 | - USD | -100.0% |
| 2011 Q1 | 181.00 USD | 154.93% |
| 2011 Q3 | 45.88 Thousand USD | 0.0% |
| 2011 FY | - USD | -100.0% |
| 2010 Q2 | - USD | -100.0% |
| 2010 Q4 | 71.00 USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | 22.96 Thousand USD | 16.05% |
| 2010 FY | 71.00 USD | -99.64% |
| 2009 Q3 | 20.92 Thousand USD | 0.97% |
| 2009 Q1 | 9900.00 USD | 125.0% |
| 2009 FY | 19.78 Thousand USD | 349.66% |
| 2009 Q4 | 19.78 Thousand USD | -5.45% |
| 2009 Q2 | 20.72 Thousand USD | 109.34% |
| 2008 Q3 | 6450.00 USD | 0.0% |
| 2008 Q1 | 6450.00 USD | 104.76% |
| 2008 FY | 4400.00 USD | 39.68% |
| 2008 Q4 | 4400.00 USD | -31.78% |
| 2008 Q2 | 6450.00 USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | 3150.00 USD | 0.0% |
| 2007 Q4 | 3150.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| BioElectronics Corporation | 16.62 Million USD | 98.342% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | 59.326% |
| Polarean Imaging plc | 2.58 Million USD | 89.32% |
| Avitar, Inc. | 11.59 Million USD | 97.623% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | 56.528% |
| AVITA Medical, Inc. | 19.86 Million USD | 98.613% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 86.987% |
| Össur hf. | 688.8 Million USD | 99.96% |
| Zecotek Photonics Inc. | 5.86 Million USD | 95.304% |
| QHSLab, Inc. | 2.05 Million USD | 86.601% |
| Wellstar International, Inc. | 55.99 Million USD | 99.508% |
| Össur hf. | 688.8 Million USD | 99.96% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 98.286% |
| Escalon Medical Corp. | 2.94 Million USD | 90.652% |
| Aurora Spine Corporation | 6.65 Million USD | 95.858% |
| BrainsWay Ltd. | 15.31 Million USD | 98.2% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 95.416% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 99.399% |
| Vivos Inc. | 245 Thousand USD | -12.494% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.989% |
| Kelyniam Global, Inc. | 1.01 Million USD | 72.791% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 88.75% |
| Nanomix Corporation | 14.81 Million USD | 98.14% |
| Theraclion SA | 13.01 Million EUR | 97.883% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 94.621% |
| Positron Corporation | 2.02 Million USD | 86.396% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 92.389% |
| Lombard Medical, Inc. | 53.79 Million USD | 99.488% |
| ALR Technologies Inc. | 24.5 Million USD | 98.875% |
| Stratec SE | 271.97 Million USD | 99.899% |
| Vycor Medical, Inc. | 4.31 Million USD | 93.617% |
| Heart Tronics, Inc. | 1.09 Million USD | 74.825% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 88.315% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 94.967% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 99.58% |
| VMS Rehab Systems, Inc. | 201.36 USD | -136776.242% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 94.966% |
| Ingen Technologies, Inc. | 5.7 Million USD | 95.173% |
| Odyssey Group International, Inc. | 6.61 Million USD | 95.831% |
| United American Healthcare Corporation | 119 Thousand USD | -131.608% |
| ECGI Holdings, Inc. | 11.94 Million USD | 97.692% |
| Capital Group Holdings, Inc. | 1.32 Million USD | 79.183% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 80.944% |
| Urologix, Inc. | 12.64 Million USD | 97.82% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 94.892% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 96.751% |
| SS Innovations International, Inc. | 11.18 Million USD | 97.535% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | 47.541% |
| Smith & Nephew plc | 4.76 Billion USD | 99.994% |
| NIOX Group Plc | 9.8 Million USD | 97.188% |
| Fuse Medical, Inc. | 15.11 Million USD | 98.176% |
| Broncus Holding Corporation | 10.43 Million USD | 97.358% |
| Brain Scientific Inc. | 7.42 Million USD | 96.289% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 99.185% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | 65.291% |